Medical Device News Magazine

Qmetrics Technologies and 20/15 Visioneers Announce Go-to-Market Partnership

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Today, 20/15 Visioneers LLC., a leading, advanced science and technology management consulting and marketing services company and Qmetrics Technologies, a leader in medical image analysis, announced a partnership to introduce an innovative assessment of mTBI/concussion severity.

Qmetrics’ Concussion Index delivers a number derived from multiple 3D features of a single conventional MRI exam that provides an objective indicator of post-concussive microtrauma severity. The higher the number, the more severe the post-concussive injury.

“Concussions are largely diagnosed and managed via patient symptoms,” says Edward Schreyer, CEO, Qmetrics Technologies. “Post-concussive brain injuries are typically too subtle to be seen by the human eye. Our technology-driven Concussion Index uses algorithms to identify post-concussive injuries. As a parent of two kids who play contact sports, I’m excited that we are partnering with 20/15 Visioneers to raise awareness of this objective assessment of concussions. Hopefully, it will lead to improved management of mTBI and better long-term outcomes.”

“20/15 Visioneers is an in silico-first leader in consulting and has discovered the life-changing capabilities that Qmetrics’ patented Artificial Intelligence and Machine Learning technology can do for concussion patients and athletes. This innovative technology can improve concussive understanding and time to heal and ultimately enhance the safety of many contact sports and potentially prevent CTE. ” John F. Conway, Chief Visioneer Officer, 20/15 Visioneers.

Read the Whitepaper “Is it Safe to Play Again” here: https://www.20visioneers15.com/blog

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”